Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance

Area of Science:

• Immunology
• Molecular Biology
• Autoimmunity

Background:

• CD8 T cells normally target pathogens but tolerate self-antigens to prevent autoimmunity.
• CD4 regulatory T cells are key in tolerance, but CD8 T cells also possess regulatory functions.
• The molecular mechanisms underlying CD8 T-cell peripheral tolerance require further elucidation.

Purpose of the Study:

• To investigate the molecular basis of peripheral CD8 T-cell tolerance.
• To identify factors contributing to antigen-specific CD8 T-cell tolerance.
• To understand the regulatory capacity of tolerized CD8 T cells.

Main Methods:

• Utilized a double transgenic mouse model for neonatal CD8 T-cell tolerance induction.
• Analyzed gene expression in tolerized CD8 T cells.
• Performed in vitro assays (genetic deletion, antibody blocking) to assess DKK3 function.
• Conducted in vivo studies involving tumor models and skin grafts.

Main Results:

• Dickkopf-3 (DKK3) expression was identified in tolerized CD8 T cells and found essential for tolerance.
• In vitro, DKK3 deletion or blockade restored CD8 T-cell proliferation and IL-2 production.
• Exogenous DKK3 suppressed CD8 T-cell reactivity.
• In vivo, DKK3 inhibition reversed tolerance, leading to tumor eradication and graft rejection.

Conclusions:

• DKK3 is a critical immune modulator essential for maintaining CD8 T-cell peripheral tolerance.
• DKK3 actively suppresses CD8 T-cell responses against self-antigens.
• Targeting DKK3 may offer therapeutic strategies for autoimmunity, cancer immunotherapy, and transplantation.